Evotec and Roche agree to develop compound that could slow the progression of Alzheimer’s disease 06 Sep 2011 News
Urgent action is needed over new drugs for mental illness A funding crisis threatens development of new treatments for mental illness. There needs to be a renewed effort to tackle Europe’s foremost health care challenge – which is currently costing €386 billion per annum 30 Jun 2011 News
Ablynx receives €5M from Alzheimer's disease collaboration with Boehringer Ingelheim 29 Jun 2011 News
Karolinska: Key to blood-brain barrier opens way for treating Alzheimer’s and stroke 20 Oct 2010 News